ResMed Market Sentiment

ResMed Inc

RMDNYSE

Trade with Public

$253.06

N/A

最終更新: Oct 22, 5:46 PM

概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

決算: Q1 2027 Q1 2027のこれから木 10 29thの6 日後決算、マーケットクローズ後。

決算説明会: 6 日後4:30 午後に電話会議が予定されています。

クリックしてウェブキャストを見る

ResMed Market Sentiment - Benzinga

ResMed Market Sentiment

Market sentiment signals for ResMed (RMD): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Neutral

Short Interest▲ 10.2% short float

Options Flow— N/A

Insider Activity— Neutral (30d)

Analyst Consensus

Neutral

21 analysts

Options Flow (P/C)

—

Avg Consensus PT

$246

-3.0%

Highest Price Target

$325

+28.4%

UBS

Lowest Price Target

$180

-28.9%

Wolfe Research

Short Interest

10.2%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 15, 2026	RBC Capital	Craig Wong-Pan—	+3.5%	$244 → $262	Upgrade	Sector Perform→Outperform
Aug 31, 2026	Keybanc	Brett Fishbin—	+5.5%	$255 → $267	Maintained	Overweight
Aug 19, 2026	Rothschild & Co	Jackson Philips—	-9.1%	$230	Initiate	Neutral
Aug 7, 2026	RBC Capital	Craig Wong-Pan—	-3.6%	$234 → $244	Maintained	Sector Perform
Aug 7, 2026	Piper Sandler	Adam Maeder—	-11.1%	$233 → $225	Maintained	Neutral
Aug 7, 2026	Keybanc	Brett Fishbin—	+0.8%	$260 → $255	Maintained	Overweight
Aug 7, 2026	Wells Fargo	Nathan Treybeck—	-15.0%	$225 → $215	Maintained	Equal-Weight
Jul 15, 2026	Mizuho	Anthony Petrone—	-13.1%	$235 → $220	Maintained	Outperform
Jul 13, 2026	Citigroup	Laura Sutcliffe—	-7.1%	$270 → $235	Downgrade	Buy→Neutral
Jul 10, 2026	Jefferies	Matthew Taylor—	-11.1%	$240 → $225	Maintained	Hold
Jul 8, 2026	RBC Capital	Craig Wong-Pan—	+9.1%	$321 → $276	Maintained	Outperform
Jul 8, 2026	Wells Fargo	Nathan Treybeck—	-11.1%	$227 → $225	Maintained	Equal-Weight
Jun 22, 2026	Keybanc	Justin Patterson—	+5.1%	$290 → $266	Maintained	Overweight
Jun 17, 2026	Morgan Stanley	David Bailey—	-9.1%	$286 → $230	Downgrade	Overweight→Equal-Weight
Jun 15, 2026	Citigroup	Laura Sutcliffe—	+6.7%	$340 → $270	Maintained	Buy
May 1, 2026	RBC Capital	Craig Wong-Pan—	+26.8%	$314 → $321	Maintained	Outperform
May 1, 2026	Wells Fargo	Nathan Treybeck—	-10.3%	$270 → $227	Maintained	Equal-Weight
Apr 27, 2026	Keybanc	Brett Fishbin—	+14.6%	$302 → $290	Maintained	Overweight
Apr 15, 2026	JP Morgan	David Low—	—	—	Reinstates	Overweight
Apr 9, 2026	Citigroup	Laura Sutcliffe—	+34.4%	$345 → $340	Maintained	Buy
Feb 2, 2026	Citigroup	Laura Sutcliffe—	+36.3%	$330 → $345	Maintained	Buy
Jan 30, 2026	RBC Capital	Craig Wong-Pan—	+24.1%	$311 → $314	Maintained	Outperform
Jan 30, 2026	Piper Sandler	Adam Maeder—	+8.7%	$270 → $275	Maintained	Neutral
Jan 30, 2026	Wells Fargo	Nathan Treybeck—	+6.7%	$265 → $270	Maintained	Equal-Weight
Jan 30, 2026	Stifel	Jonathan Block—	+4.7%	$260 → $265	Maintained	Hold